Repligen Corporation (RGEN) vs Solventum Corporation (SOLV)

Repligen Corporation and Solventum Corporation are both Medical Instruments & Supplies companies. Solventum Corporation is the larger, with a market value of $14.8B against $10.8B — 1.4× the size. Repligen Corporation has negative trailing earnings, so its P/E is not meaningful; Solventum Corporation trades at 97.3×. Repligen Corporation grew revenue faster over the last twelve months: 13.8% against −2.84%. Solventum Corporation has the higher net margin (1.91% vs −1.47%) and the lower return on invested capital (0.00% vs 0.64%). Across the 18 metrics below, Repligen Corporation leads on 9 and Solventum Corporation on 9.

Valuation

Metric RGEN SOLV Medical Instruments & Supplies median
P/E n/m 97.26 30.28
P/S 11.87 1.81 2.49
P/B 4.57 3.08 2.34
Price to free cash flow 170.11 n/m 23.49
EV/EBITDA 60.12 7.60 14.87
EV/Sales 11.57 2.40 2.75
Earnings yield (0.12%) 1.03% 0.00%
Free cash flow yield 0.59% 0.00% 0.59%

Profitability

Metric RGEN SOLV Medical Instruments & Supplies median
Gross margin 53.46% 0.00% 53.60%
Operating margin 2.26% 0.00% 1.97%
Net margin (1.47%) 1.91% 0.00%
Free cash flow margin 13.09% 0.00% 2.36%
Return on equity (0.57%) 3.19% 0.00%
Return on assets (0.40%) 1.11% 0.00%
Return on invested capital 0.64% 0.00% 0.13%

Growth

Metric RGEN SOLV Medical Instruments & Supplies median
Revenue growth (TTM) 13.80% (2.84%) 8.97%
EPS growth (last fiscal year) 286.96% 221.74% 6.51%
Revenue growth, 5-year CAGR 15.05% — 8.85%
Net income growth, 5-year CAGR (3.99%) — 0.00%

Health

Metric RGEN SOLV Medical Instruments & Supplies median
Debt to equity 0.27 0.11 0.10
Current ratio 9.88 1.03 2.47
Net debt to EBITDA (1.50) 1.56 0.97

Dividend

Metric RGEN SOLV Medical Instruments & Supplies median
Dividend yield — — 1.02%
Payout ratio — — 0.27

Size

Metric RGEN SOLV Medical Instruments & Supplies median
Market cap 10.77b 14.84b 1.71b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack